Literature DB >> 21907581

P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis.

Amelia Conte1, Serena Lattante, Marcella Zollino, Giuseppe Marangi, Marco Luigetti, Alessandra Del Grande, Serenella Servidei, Federica Trombetta, Mario Sabatelli.   

Abstract

Some FUS mutations have been observed in patients with the juvenile form of Amyotrophic Lateral Sclerosis starting before 25 years. We report an 11-year-old girl affected by sporadic juvenile ALS with a rapid course resulting in tracheostomy after 14 months from the onset. Sequencing FUS gene revealed a de novo P525L mutation. Our findings, together with literature data, indicate that this mutation is consistently associated with a specific phenotype characterized by juvenile onset, severe course and high proportion of de novo mutations in sporadic cases.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907581     DOI: 10.1016/j.nmd.2011.08.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  42 in total

1.  Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression.

Authors:  Zhang-Yu Zou; Ming-Sheng Liu; Xiao-Guang Li; Li-Ying Cui
Journal:  Ann Transl Med       Date:  2015-09

Review 2.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

3.  Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.

Authors:  Michael Tibshirani; Miranda L Tradewell; Katie R Mattina; Sandra Minotti; Wencheng Yang; Hongru Zhou; Michael J Strong; Lawrence J Hayward; Heather D Durham
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

4.  Activity-dependent FUS dysregulation disrupts synaptic homeostasis.

Authors:  Chantelle F Sephton; Amy A Tang; Ashwinikumar Kulkarni; James West; Mieu Brooks; Jeremy J Stubblefield; Yun Liu; Michael Q Zhang; Carla B Green; Kimberly M Huber; Eric J Huang; Joachim Herz; Gang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-16       Impact factor: 11.205

5.  De novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case.

Authors:  Andrea Calvo; Cristina Moglia; Antonio Canosa; Maura Brunetti; Marco Barberis; Bryan J Traynor; Giovanna Carrara; Consuelo Valentini; Gabriella Restagno; Adriano Chiò
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

6.  The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.

Authors:  Xinxiu Liu; Jiayu Chen; Wenchao Liu; Xiaogang Li; Qi Chen; Tao Liu; Shaorong Gao; Min Deng
Journal:  Neurogenetics       Date:  2015-04-26       Impact factor: 2.660

Review 7.  Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD.

Authors:  Hongbo Chen; Mark W Kankel; Susan C Su; Steve W S Han; Dimitry Ofengeim
Journal:  Cell Death Differ       Date:  2018-02-19       Impact factor: 15.828

8.  Treatment with a Global Methyltransferase Inhibitor Induces the Intranuclear Aggregation of ALS-Linked FUS Mutant In Vitro.

Authors:  Sakiko Fujii; Keisuke Takanashi; Keiko Kitajo; Atsushi Yamaguchi
Journal:  Neurochem Res       Date:  2015-11-24       Impact factor: 3.996

9.  Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation.

Authors:  Zhenying Liu; Shengnan Zhang; Jinge Gu; Yilun Tong; Yichen Li; Xinrui Gui; Houfang Long; Chuchu Wang; Chunyu Zhao; Jinxia Lu; Lin He; Ying Li; Zhijun Liu; Dan Li; Cong Liu
Journal:  Nat Struct Mol Biol       Date:  2020-03-30       Impact factor: 15.369

Review 10.  Gene therapy for ALS: A review.

Authors:  Defne A Amado; Beverly L Davidson
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.